Developing Hybrid Polymer Scaffolds Using Peptide Modified Biopolymers for Cell Implantation

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cellular Therapy

Background:

• Polymeric scaffolds with biomimics show promise for cellular therapies.
• Existing methods face challenges with foreign body reactions and cell viability.
• Improving scaffold integration is crucial for successful cell transplantation.

Purpose of the Study:

• To design and fabricate a hybrid scaffold that prevents foreign body reactions.
• To maintain cell viability within the scaffold for enhanced therapeutic outcomes.
• To investigate the potential of this scaffold in improving cell transplantation success rates.

Main Methods:

• Developed a biodegradable, acrylic-based, cross-linkable polycaprolactone polymer.
• Fabricated hybrid scaffolds using a multihead electrospinning station.
• Incorporated cell growth factor mimics and anti-foreign body reaction factors into the scaffold.

Main Results:

• Transplantation studies in immuno-competent and immuno-suppressed mice demonstrated extensive neo-vascularization.
• Maintained neonatal porcine islet cell viability for up to 20 weeks post-transplant in subcutaneous implants.
• The scaffold successfully prevented adverse foreign body reactions.

Conclusions:

• This novel hybrid scaffold approach enhances revascularization in cell transplantation.
• The scaffold design supports long-term cell viability and integration.
• This technology offers a promising strategy for improving cellular therapies.